China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effective dose of alfentanil combined with remimazolam for inhibition of gastroscopy insertion reaction in obese patients'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136234
Registration Time: 2026/11/09
Type: Interventional study
Primary Sponsor: Jiaxing Second Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=293202
Published by HT Digital Content Services with permission from Health Daily Digest....